*AdvaCare Diclazuril Oral Suspension is GMP certified.
**AdvaCare Diclazuril Oral Suspension is manufactured in our facilities located in China/India/USA.
2.5%
100ml bottle/box;500ml bottle/box;1000ml bottle/box
Anticoccidial, Antiprotozoal
Diclazuril
Product Information
General Information:
AdvaCare is a GMP manufacturer of Diclazuril oral suspensions.
Diclazuril is a new anticoccidial drug. It is used in the treatment and prevention of coccidial infections in chickens and lambs caused in particular, by the more pathogenic Eimeria species E. crandallis and E. ovinoidalis. Diclazuril oral suspension aid in the control of coccidiosis in calves caused by Eimeria bovis and Eimeria zuernii.
Diclazuril is an anticoccidial of the benzeneacetonitrile group. It has a coccidiocidal effect on the asexual or sexual stages of the development cycle of the parasite.
Treatment with diclazuril causes interruption of the coccidial cycle and reduces excretion of oocysts for up to 14 days.
Side Effects:
As with all veterinary products some unwanted effects can occur. Always consult a veterinary physician or animal care specialist for medical advice before use.
No side effects have been detected yet if you notice any serious effects or other effects not mentioned on this package, please inform your veterinary surgeon.
If any symptom persists or gets worse, or you notice any other symptom, then please seek veterinary medical treatment immediately.
-
For more information about our Diclazuril Oral Suspension
email us at: info@advacarepharma.com
Additional Information
Always consult a veterinary physician or animal care specialist before using diclazuril oral suspension. If the condition does not improve or becomes worse, then call a veterinary physician or animal care specialist.
Indications and Usage
Diclazuril oral suspension is indicated in the treatment and prevention of coccidial infections in lambs caused by Eimeria crandallis or Eimeria ovinoidalis and in calves caused by Eimeria bovis or Eimeria zuernii.
Diclazuril is effective in the prevention and treatment of coccidial infections in poultry caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mitis (mivati), and E. maxima.
Studies have shown that diclazuril helps in reducing lesion scores and improve the performance and health of birds challenged with E. maxima.
Contraindications
Do not use in layers producing eggs for human consumption.
Administration and Dosage
Do not administer doses greater than 1ml/25kg of body weight in calves and lambs and 0.002ml/kg of body weight in rabbit, similarly administer doses greater than 30-67ml/1000 liters of drinking water for three days in 6 weeks in poultry. Diclazuril oral suspension shouldn’t be administered if any hypersensitivity is discovered.
Oral administration via feed or drinking water is recommended. Shake well before use. Treating of all the animals at the same time is recommended.
Refer to an animal care specialist for guidelines on dosage. Do not exceed the dosage or stop the treatment at an early stage, as stopping early can result in a recurrence or a worsening of the problem.
Precautions
Undergoing the same therapy might lead to resistance, therefore, rotation among other anticoccidials treatments is recommended. Whenever the suspension is mixed with feed, the product should be used immediately. Medicated drinking water should be used within 24 hours.
Warnings
No special warnings.
Overdose
Not known.
Interactions
Not known.
Interested in more Products?
For more antiprotozoal therapies, you can also check the following related products: